Brintellix (vortioxetine) an anti depressant from Lundbeck and Takeda Pharma has been re-named Trintellix in the US. The FDA had...
Lundbeck announced the FDA approved a supplemental new drug application for Trintellix (vortioxetine). The clinical trials section of the U.S....
H. Lundbeck A/S and its partner Takeda Pharmaceuticals USA, Inc., can once again expand the Clinical Trials section of the...
H. Lundbeck A/S (Lundbeck) recently completed a global Phase IV, randomized, comparative study exploring the role of vortioxetine as a treatment option between SSRIs and serotonin–noradrenaline reuptake inhibitors (SNRIs).